Erratum in: “Cyclin-Dependent Kinase Inhibitor 2b Mediates Excitotoxicity-Induced Death of Retinal Ganglion Cells” by Hiroshi Tawarayama, Qiwei Feng, Namie Murayama, Noriyuki Suzuki, and Toru Nakazawa (
Invest Ophthalmol Vis Sci. 2019;60:4479–4488),
https://doi.org/10.1167/iovs.19-27396.
When the article was first published, the title was “Cyclin-Dependent Kinase Inhibitor 2b Attenuates Excitotoxicity-Induced Death of Retinal Ganglion Cells.” The title has been changed in the published article and in the supplementary material to “Cyclin-Dependent Kinase Inhibitor 2b Mediates Excitotoxicity-Induced Death of Retinal Ganglion Cells.”
The author affiliations were originally published as follows:
1Department of Ophthalmology, Tohoku Graduate University School of Medicine, Sendai, Japan
2Division of Retinal Disease Control, Tohoku Graduate University School of Medicine, Sendai, Japan
3Division of Advanced Ophthalmic Medicine, Tohoku Graduate University School of Medicine, Sendai, Japan
They have been corrected in the published article as follows:
1Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan
2Division of Retinal Disease Control, Tohoku University Graduate School of Medicine, Sendai, Japan
3Division of Advanced Ophthalmic Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan